Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37643378

Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2023 Nov 20
First author
Hargrave DR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Nov;20(11):734. doi: 10.1038/s41571-023-00820-8.
    note
    Source null
    related pmid
    37726419
    relationship
    Comment in

Authors and identifiers

  1. name
    Hargrave DR
    type
    Author
  2. name
    Terashima K
    type
    Author
  3. name
    Hara J
    type
    Author
  4. name
    Kordes UR
    type
    Author
  5. name
    Upadhyaya SA
    type
    Author
  6. name
    Sahm F
    type
    Author
  7. name
    Bouffet E
    type
    Author
  8. name
    Packer RJ
    type
    Author
  9. name
    Witt O
    type
    Author
  10. name
    Sandalic L
    type
    Author
  11. name
    Kieloch A
    type
    Author
  12. name
    Russo M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hargrave DR
    type
    Author
  2. name
    Terashima K
    type
    Author
  3. name
    Hara J
    type
    Author
  4. name
    Kordes UR
    type
    Author
  5. name
    Upadhyaya SA
    type
    Author
  6. name
    Sahm F
    type
    Author
  7. name
    Bouffet E
    type
    Author
  8. name
    Packer RJ
    type
    Author
  9. name
    Witt O
    type
    Author
  10. name
    Sandalic L
    type
    Author
  11. name
    Kieloch A
    type
    Author
  12. name
    Russo M
    type
    Author
bibliography ids
  1. nci-bib-5b996082236b402cea53dbec
book metadata
content sha256
21ddc706bcb94ea1aade9ba0f8ce0ba855cb84018df278fc47ee119e1abd1917
document type
citation
dois
  1. 10.1200/JCO.23.00558
electronic publication date
display
2023 Aug 29
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37643378
immutable id
pubmed:37643378@21ddc706bcb94ea1aade9ba0f8ce0ba855cb84018df278fc47ee119e1abd1917
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
33
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
5174-5183
volume
41
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2023 Nov;20(11):734. doi: 10.1038/s41571-023-00820-8.
    note
    Source null
    related pmid
    37726419
    relationship
    Comment in
outcomes validated
false
pmid
37643378
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
162da1816a65d86a2fe6b19131fde0cd83ea6329854af151056e22ccb3db4828
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Nov 20
precision
day
year
2023
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37643378/
title
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.

Preserved source evidence · Not medical advice